Jullin Fjeldstad
About Jullin Fjeldstad
Title
Jullin Fjeldstad holds the position of Head of Clinical Embryology and Scientific Operations. In this role, she oversees various scientific and operational aspects within the realm of clinical embryology. Her responsibilities include the integration of new technologies in laboratories and managing scientific collaboration projects.
Education and Expertise
Jullin Fjeldstad earned a Bachelor of Science (BSc) in Biology from the University of Victoria. She further specialized by completing a Master of Science (MSc) in Clinical Embryology from the University of Leeds in the United Kingdom. With this strong educational foundation, she has developed profound expertise in innovative Assisted Reproductive Technologies (ART) and clinical embryology workflows.
Career and Professional Background
Jullin Fjeldstad began her career in the field of fertility at a Canadian in-vitro fertilization (IVF) clinic in 2006. She quickly advanced to the roles of senior embryologist and eventually laboratory director. Her career trajectory demonstrates significant growth and accomplishment in the fertility sector. Jullin now works intimately with partnering clinics to ensure the successful onboarding and implementation of new technological systems within their laboratories.
Scientific Collaborations
In her capacity as Head of Clinical Embryology and Scientific Operations, Jullin Fjeldstad oversees various scientific project collaborations. Her role entails coordinating with research teams and facilitating the smooth execution of joint scientific endeavors. Jullin also presents her research findings at international IVF conferences, contributing to the global conversation on advancements in clinical embryology and fertility treatment.
Innovation in Assisted Reproductive Technologies
Jullin Fjeldstad has a long-standing passion for innovative Assisted Reproductive Technologies (ART). Her work focuses on the continuous improvement of IVF outcomes and the enhancement of the fertility journey for patients. Through her role and research, she is committed to driving advances that make fertility treatments more effective and accessible.